Setting ROKIT Genomics apart is its team of PhD-level scientists with hands-on experience in single-cell research. These experts, many of whom were early adopters of single-cell RNA-seq (scRNA-seq) technology, offer a rare blend of experimental and computational insight, bringing technical excellence and a deep understanding of the scientific questions that drive discovery.
"We provide expert-led services that let researchers focus on their biological questions, while we take care of the technical complexities," says TaeWoo Kwon, CEO.
The field of single-cell transcriptomics is growing rapidly, driven by the need to understand cellular heterogeneity better. As it expands, researchers are increasingly challenged by the complexity of the technologies and data involved.
One of the most critical and often overlooked challenges is tissue dissociation. Unlike bulk RNA-seq, which provides an averaged gene expression profile across thousands of cells, scRNA-seq requires a precise, customized approach at every step. Different tissues, species and models, such as organoids, make applying a one-size-fits-all isolation protocol impossible. In addition, many researchers lack a background in computational biology or coding, which limits their ability to extract insight from complex data.
ROKIT Genomics addresses these challenges by stepping into the researcher’s shoes. Drawing on published methods and pilot studies, the team identifies the most effective strategies to ensure optimal tissue dissociation, even in the most intricate biological systems.
-
We provide expert-led services that let researchers focus on their biological questions, while we take care of the technical complexities
Its flexible multiplexing strategies, (including antibody-, probe-, and non-labeling-based methods) allow multiple samples to be processed simultaneously with a single reagent set, significantly improving cost-efficiency and throughput. Supporting a wide range of platforms, including 10x Genomics, BD Rhapsody and MobiDrop, it adapts to the unique needs of every project. As a designated reference lab for BD Biosciences, the team is also among the first to deploy and validate emerging applications, ensuring clients benefit from the latest advancements in the field. Its support often extends to project design, troubleshooting and manuscript preparation. The pre-analysis consultation ensures that clients receive the most relevant results.
To help researchers unlock insights from complex data, ROKIT Genomics provides fully customized, user-centric bioinformatics services. Each analysis is tailored to the specific needs of the project. This approach generates publication-ready figures and insights, all at a cost that makes high-level genomics more accessible.
Robust custom coding pipelines combined with intuitive web-based tools, such as CDIAM by Pythia, accommodate users of all bioinformatics skill levels. This flexibility ensures that researchers, from bioinformatics novices to seasoned computational scientists, can access the insights they need with confidence.
Driven by groundbreaking technical innovation, ROKIT Genomics continues to earn the trust of government research institutions, universities, and hospitals across Korea. Its leadership in the field was further recognized with the prestigious 2024 R&D Excellence Award. At its core, the organization is committed to delivering precisely what researchers need, not just what the platform allows.
While oncology remains the primary driver of demand, followed by stem cell and organoid research, the technology is now extending beyond human studies to include a variety of animal models. This expansion further reinforces its status as an indispensable platform, much like PCR became essential in molecular biology.
As genomics enters a new era of complexity, ROKIT Genomics rises to the challenge, providing researchers with the expertise and support needed to push the boundaries of single-cell transcriptomics.
Single Cell Sequencing Service Info
Why is ROKIT Genomics recognized among leading Single Cell Sequencing Services providers?
ROKIT Genomics has built its reputation in Single Cell Sequencing Services by making complex single-cell transcriptome analysis more accessible to academic, clinical, and industry researchers. The company delivers end-to-end single-cell RNA sequencing workflows that include sample quality control, cell capture, library preparation, sequencing, and bioinformatics analysis. Its expertise is reinforced by a team of PhD-level scientists with early adoption experience in single-cell RNA sequencing technologies, enabling it to guide researchers through both experimental design and data interpretation.
What differentiates ROKIT Genomics in the single-cell sequencing landscape?
A key differentiator for ROKIT Genomics within Single Cell Sequencing Services is its ability to combine experimental precision with computational insight. The company supports multiple platforms including 10x Genomics Chromium, BD Rhapsody, and MobiDrop systems, allowing researchers to choose workflows tailored to specific study needs. It also integrates multiplexing strategies and customized tissue dissociation guidance, which improves data quality in complex biological samples where single-cell isolation is challenging.
How does ROKIT Genomics support researchers throughout the sequencing workflow?
ROKIT Genomics provides a structured, end-to-end Single Cell Sequencing Services pipeline that begins with consultation and sample preparation guidance and continues through sequencing and downstream analysis. The process includes sample quality checks, library construction, sequencing on Illumina platforms, and tailored bioinformatics analysis such as clustering, differential expression, and pathway analysis. This workflow-driven approach ensures that researchers can focus on biological questions while the technical complexity is managed through standardized protocols.
What types of biological research benefit most from its services?
Single Cell Sequencing Services offered by ROKIT Genomics are widely used in oncology, immunology, stem cell research, and organoid studies. The platform is particularly valuable for uncovering cellular heterogeneity, identifying rare cell populations, and understanding tumor microenvironment dynamics. By analyzing gene expression at the individual cell level, researchers can gain insights into disease progression, immune response variability, and developmental biology mechanisms that are often masked in bulk sequencing approaches.
How does ROKIT Genomics ensure data quality and analytical reliability?
Quality assurance is embedded across all Single Cell Sequencing Services through strict sample quality criteria, standardized library preparation protocols, and validated sequencing workflows. The company applies viability thresholds, optimized cell capture strategies, and platform-specific protocols to ensure high-quality input data. Post-sequencing, specialized bioinformatics pipelines refine clustering, gene expression profiling, and cell-state interpretation, improving reproducibility and analytical confidence across studies.
Why is ROKIT Genomics relevant to modern precision medicine and genomics research?
ROKIT Genomics remains highly relevant in Single Cell Sequencing Services due to the growing demand for high-resolution cellular profiling in precision medicine. As research shifts toward understanding disease at the cellular level, the ability to analyze individual cell behavior becomes critical for therapeutic development and biomarker discovery. The company’s combination of advanced sequencing platforms, computational expertise, and customized analytical support positions it as a key enabler of next-generation genomic research.
